# Seroquel XR in the Long Term Treatment of Schizophrenia

> **NCT01202617** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1606 (actual)

## Conditions studied

- Relapse in Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01202617
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 1606 (ACTUAL)
- **Last updated:** 2011-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202617, "Seroquel XR in the Long Term Treatment of Schizophrenia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01202617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*